IMMUNOCORE HLDGS ADS/1 Working Capital to Net Assets Ratio
IMMUNOCORE HLDGS ADS/1 working capital to net assets ratio. IMMUNOCORE HLDGS ADS/1 (6YG) has a Working Capital to Net Assets ratio of 194.3% as of June 2026. Working capital of €815.85 Million (current assets of €1.05 Billion minus current liabilities of €235.20 Million) is measured against net assets of €419.80 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check 6YG tangible net assets ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of IMMUNOCORE HLDGS ADS/1 (2022–2025)
Working capital to net assets ratio of IMMUNOCORE HLDGS ADS/1 from 2022 to 2025. This chart shows how IMMUNOCORE HLDGS ADS/1's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the ratio stands at 194.3%, reflecting working capital of €815.85 Million against net assets of €419.80 Million EUR. See defensive interval ratio of IMMUNOCORE HLDGS ADS/1 to measure how many days the company can operate on defensive assets alone.
IMMUNOCORE HLDGS ADS/1 Working Capital to Net Assets Ratio by Year (2022–2025)
IMMUNOCORE HLDGS ADS/1 working capital to net assets ratio by year from 2022 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for IMMUNOCORE HLDGS ADS/1 from 2022 to 2025, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 6YG asset base.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 196.8% | €750.04 Million | €381.03 Million | €996.74 Million | €246.70 Million | ▼ -2.1 pp |
| 2024 | 199.0% | €717.68 Million | €360.72 Million | €929.86 Million | €212.18 Million | ▲ +93.3 pp |
| 2023 | 105.7% | €389.80 Million | €368.84 Million | €528.82 Million | €139.02 Million | ▼ -4.4 pp |
| 2022 | 110.1% | €373.14 Million | €338.90 Million | €473.98 Million | €100.83 Million | — |